THBS1 and neoplasm: TAX2 peptide targets matricellular thrombospondin-1 (TSP-1) at the CD47 binding site, therefore antagonizing TSP-1:CD47 interaction which is known to play a key role in both immune and angiogenic tumor responses21, 22.